Glaukos Corporation (NYSE:GKOS) was downgraded by investment analysts at BidaskClub from a “hold” rating to a “sell” rating in a note issued to investors on Saturday.

GKOS has been the subject of several other research reports. Zacks Investment Research upgraded Glaukos Corporation from a “hold” rating to a “strong-buy” rating and set a $48.00 price objective for the company in a report on Tuesday, July 4th. Roth Capital decreased their price objective on Glaukos Corporation from $60.00 to $54.00 and set a “buy” rating for the company in a report on Thursday. TheStreet lowered Glaukos Corporation from a “c” rating to a “d+” rating in a report on Wednesday, May 3rd. Cantor Fitzgerald reiterated an “overweight” rating and set a $54.00 price objective on shares of Glaukos Corporation in a report on Thursday, May 4th. Finally, BMO Capital Markets reiterated a “buy” rating and set a $54.00 price objective on shares of Glaukos Corporation in a report on Tuesday, April 11th. One equities research analyst has rated the stock with a sell rating and eight have assigned a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $52.33.

Shares of Glaukos Corporation (NYSE:GKOS) opened at 36.26 on Friday. The company’s market cap is $1.25 billion. The firm has a 50 day moving average price of $41.36 and a 200-day moving average price of $43.37. Glaukos Corporation has a 12-month low of $28.26 and a 12-month high of $52.49.

WARNING: This story was first posted by Daily Political and is the property of of Daily Political. If you are accessing this story on another publication, it was copied illegally and reposted in violation of international copyright laws. The legal version of this story can be viewed at https://www.dailypolitical.com/2017/08/07/glaukos-corporation-gkos-downgraded-by-bidaskclub-to-sell.html.

Several institutional investors have recently added to or reduced their stakes in GKOS. State Board of Administration of Florida Retirement System increased its position in Glaukos Corporation by 1.9% in the fourth quarter. State Board of Administration of Florida Retirement System now owns 7,699 shares of the medical instruments supplier’s stock valued at $264,000 after buying an additional 140 shares during the last quarter. Inspirion Wealth Advisors LLC increased its position in Glaukos Corporation by 7.4% in the first quarter. Inspirion Wealth Advisors LLC now owns 9,400 shares of the medical instruments supplier’s stock valued at $482,000 after buying an additional 650 shares during the last quarter. American International Group Inc. increased its position in Glaukos Corporation by 7.1% in the first quarter. American International Group Inc. now owns 10,293 shares of the medical instruments supplier’s stock valued at $528,000 after buying an additional 681 shares during the last quarter. Teachers Advisors LLC increased its position in Glaukos Corporation by 5.7% in the fourth quarter. Teachers Advisors LLC now owns 27,789 shares of the medical instruments supplier’s stock valued at $953,000 after buying an additional 1,506 shares during the last quarter. Finally, Great West Life Assurance Co. Can purchased a new position in Glaukos Corporation during the first quarter valued at about $102,000. 89.63% of the stock is currently owned by hedge funds and other institutional investors.

Glaukos Corporation Company Profile

Glaukos Corporation is an ophthalmic medical technology company. The Company focuses on the development and commercialization of products and procedures for the treatment of glaucoma. It offers iStent, a micro-invasive glaucoma surgery (MIGS) device. The iStent is a micro-bypass stent inserted through the small corneal incision made during cataract surgery and placed into Schlemm’s canal, a circular channel in the eye that collects aqueous humor and delivers it back into the bloodstream.

Analyst Recommendations for Glaukos Corporation (NYSE:GKOS)

Receive News & Ratings for Glaukos Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glaukos Corporation and related companies with MarketBeat.com's FREE daily email newsletter.